Virtu KCG Holdings’s Kite Pharma, Inc. KITE Stock Holding History

Virtu KCG Holdings’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,263	Closed	-$335K	–	3859
2017 Q1	$335K	Sell	4,263 -26,848	-86%	-$1.66M	0.01%	1808
2016 Q4	$1.4M	Buy	+31,111	New	+$1.53M	0.03%	512
2016 Q3	–	Sell	-8,817	Closed	-$441K	–	3724
2016 Q2	$441K	Buy	8,817 +3,754	+74%	+$184K	0.01%	1485
2016 Q1	$232K	Sell	5,063 -3,347	-40%	-$162K	0.01%	1947
2015 Q4	$518K	Buy	+8,410	New	+$592K	0.01%	1496
2015 Q3	–	Sell	-4,535	Closed	-$276K	–	4103
2015 Q2	$276K	Buy	+4,535	New	+$259K	﹤0.01%	2180
2015 Q1	–	Sell	-6,337	Closed	-$365K	–	4243
2014 Q4	$365K	Buy	+6,337	New	+$267K	0.01%	2093

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Virtu KCG Holdings's KITE Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Kite Pharma, Inc. (KITE) in Q2 2017, closing a stake of 4,263 shares — an estimated $335K sold.

Virtu KCG Holdings first reported a position in KITE in Q4 2014 and held it in 7 quarters. The position peaked at $1.4M in Q4 2016. 220 funds tracked by Wall St. Rank hold KITE as of Q2 2017.

Virtu KCG Holdings reported no remaining Kite Pharma, Inc. position as of Q2 2017 after selling out during the quarter.
Virtu KCG Holdings sold 4,263 Kite Pharma, Inc. shares in Q2 2017, an estimated $335K.
Virtu KCG Holdings first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 7 quarters.
Virtu KCG Holdings's Kite Pharma, Inc. position peaked at $1.4M in Q4 2016.
220 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.